GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (XPAR:EQS) » Definitions » 3-Year EPS without NRI Growth Rate

Equasens (XPAR:EQS) 3-Year EPS without NRI Growth Rate : 19.90% (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Equasens 3-Year EPS without NRI Growth Rate?

Equasens's EPS without NRI for the six months ended in Jun. 2023 was €1.47.

During the past 12 months, Equasens's average EPS without NRI Growth Rate was 14.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 19.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Equasens was 19.90% per year. The lowest was -76.60% per year. And the median was 10.60% per year.


Competitive Comparison of Equasens's 3-Year EPS without NRI Growth Rate

For the Health Information Services subindustry, Equasens's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Equasens's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Equasens's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Equasens's 3-Year EPS without NRI Growth Rate falls into.



Equasens 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Equasens  (XPAR:EQS) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Equasens 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Equasens's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Equasens (XPAR:EQS) Business Description

Traded in Other Exchanges
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens (XPAR:EQS) Headlines

From GuruFocus

Equus Announces Second Quarter Net Asset Value

By Marketwired Marketwired 08-16-2021

Equus Announces Second Quarter Net Asset Value

By Value_Insider Value_Insider 11-14-2022

Equus Shareholders Grant Authorization to Withdraw BDC Election

By Marketwired Marketwired 08-20-2021

Equus Announces First Quarter Net Asset Value

By PurpleRose PurpleRose 07-11-2022

Equus Announces First Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 05-12-2022

Equus Announces First Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 05-22-2022

Equus Announces First Quarter Net Asset Value

By GlobeNewswire GlobeNewswire 05-14-2021

Equus Subsidiary, Morgan E&P, Acquires 4,747 Net Acres in the Bakken

By sperokesalga sperokesalga 05-22-2023

Equus Announces Second Quarter Net Asset Value

By PurpleRose PurpleRose 08-15-2022